Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Traws Pharma, Inc. (TRAW) had Earnings per Share (EPS) (Basic) of $2.17 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.06M |
|
$15.08M |
|
-- |
|
$0.06M |
|
$5.26M |
|
$-5.20M |
|
$26.69M |
|
$21.49M |
|
$21.49M |
|
$21.49M |
|
$21.49M |
|
$21.49M |
|
$21.49M |
|
$-5.20M |
|
$-5.20M |
|
6.97M |
|
7.22M |
|
|
Earnings per Share (EPS) (Basic) |
$2.17 |
$2.09 |
|
| Balance Sheet Financials | |
$18.86M |
|
$0.01M |
|
$0.21M |
|
$19.06M |
|
$10.40M |
|
-- |
|
$2.66M |
|
$13.06M |
|
$6.00M |
|
$6.00M |
|
$6.00M |
|
5.08M |
|
| Cash Flow Statement Financials | |
$-5.44M |
|
-- |
|
$0.01M |
|
$21.34M |
|
$15.94M |
|
$-5.40M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-9128.07% |
|
-9128.07% |
|
-- |
|
37701.75% |
|
26461.40% |
|
$-5.44M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.03 |
|
2611.58 |
|
358.17% |
|
358.17% |
|
112.73% |
|
358.17% |
|
$1.18 |
|
$-0.75 |
|
$-0.75 |
|